Ng'uni Tiza, Klaasen Jeremy A, Fielding Burtram C
Molecular Biology and Virology Laboratory, Department of Medical BioSciences, Faculty of Natural Sciences, University of the Western Cape, Western Cape, South Africa.
Plant Extract Laboratory, Department of Medical BioSciences, Faculty of Natural Sciences, University of the Western Cape, Western Cape, South Africa.
Toxicol Rep. 2018 Aug 13;5:813-818. doi: 10.1016/j.toxrep.2018.08.008. eCollection 2018.
Medicinal plants are used by a large proportion of the global population as complementary and alternative medicines. However, little is known about their toxicity. has been used to treat wounds, coughs and skin diseases and is used in cosmetic formulations such as lotions and shampoos.
The acute oral and dermal toxicity potential of was analyzed after a single administration of 300 and 2000 mg/kgbw for acute oral toxicity and 2000 mg/kgbw for acute dermal toxicity. Female Sprague-Dawley rats were used for the acute oral toxicity study whereas both male and female Sprague-Dawley rats were used for the acute dermal toxicity study. In the Episkin skin irritation test, the irritation potential of (concentrate) and (in-use dilution) extracts were assessed using the Episkin reconstituted human epidermis. In the dermal sensitization study, female CBA/Ca mice were treated with concentrations of 50, 100 and 200 mg/ml respectively. The vehicle of choice was dimethylformamide which acted as a control.
The results of the acute oral and dermal toxicity studies revealed that the median lethal dosage (LD) for extract in Sprague-Dawley rats was considered to exceed 2000 mg/kgbw. In the irritation test, the (concentrate) and (in-use dilution) extracts were non-irritant on the Episkin reconstituted human epidermis. In the dermal sensitization study, the stimulation index (SI) values for the mice treated with the extract at concentrations of 50, 100 and 200 mg/ml/kgbw, when compared to the control group, were 1.3, 0.9 and 1.3 respectively. The open application of the extract at the various concentrations did not result in a SI of ≥ 3 in any group. Hence, it did not elicit a hypersensitivity response.
These findings demonstrate that the acute toxicity profile for is acceptable and can subsequently be used for single use in the pharmaceutical and cosmetic industries.
全球很大一部分人口使用药用植物作为补充和替代药物。然而,人们对其毒性知之甚少。[植物名称]已被用于治疗伤口、咳嗽和皮肤病,并用于乳液和洗发水等化妆品配方中。
单次给予300和2000mg/kg体重用于急性口服毒性分析,2000mg/kg体重用于急性皮肤毒性分析,分析[植物名称]的急性口服和皮肤毒性潜力。雌性Sprague-Dawley大鼠用于急性口服毒性研究,而雄性和雌性Sprague-Dawley大鼠均用于急性皮肤毒性研究。在Episkin皮肤刺激性试验中,使用Episkin重组人表皮评估[植物名称](浓缩物)和[植物名称](使用中稀释液)提取物的刺激潜力。在皮肤致敏研究中,雌性CBA/Ca小鼠分别用浓度为50、100和200mg/ml的[植物名称]处理。选择的赋形剂是用作对照的二甲基甲酰胺。
急性口服和皮肤毒性研究结果表明,Sprague-Dawley大鼠中[植物名称]提取物的半数致死剂量(LD)被认为超过2000mg/kg体重。在刺激性试验中,[植物名称](浓缩物)和[植物名称](使用中稀释液)提取物对Episkin重组人表皮无刺激性。在皮肤致敏研究中,与对照组相比,用浓度为50、100和200mg/ml/kg体重的[植物名称]提取物处理的小鼠的刺激指数(SI)值分别为1.3、0.9和1.3。在任何组中,以各种浓度开放应用提取物均未导致SI≥3。因此,它没有引发超敏反应。
这些发现表明,[植物名称]的急性毒性特征是可接受的,随后可用于制药和化妆品行业的单次使用。